After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
Israel Financial Insider - Teva was fined 60 million euros by the European Union, in light of an agreement signed between it and Seflon in 2005 and ended in 2011, when Teva
Teva agrees $519m settlement of US anti-bribery charges | Financial Times
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceuticals - Wikipedia
Teva (TEVA) Stock Is Still Facing Major Risk at This Point | InvestorPlace
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Teva Pharmaceuticals - Wikiwand
Teva rejigs top management - Globes
Teva's Blockbuster Drug Takes Another Generic Blow | Ctech
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
EU antitrust launches probe against Israeli drugmaker Teva
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva to sell Paragard device to CooperSurgical for $1.1bn - Verdict Medical Devices
Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic Group - The Economic Times
18. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Teva Pharma wins conditional EU approval for Allergan Generics acquisition - IBTimes India
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharma opens $110M plant in Hungary | FiercePharma
